PFS
RPTX

Prospera Financial Services’s Repare Therapeutics RPTX Stock Holding History

Prospera Financial Services’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-122
Closed -$2K – 1436
2022
Q2 		$2K Hold
122
– – ﹤0.01% 1565
2022
Q1 		$2K Buy
+122
New +$1.81K ﹤0.01% 2507

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Prospera Financial Services's RPTX Position: Q3 2022 in Review

Prospera Financial Services sold out of Repare Therapeutics (RPTX) in Q3 2022, closing a stake of 122 shares — an estimated $2K sold.

Prospera Financial Services first reported a position in RPTX in Q1 2022 and held it in 2 quarters. The position peaked at $2K in Q2 2022. 71 funds tracked by Wall St. Rank hold RPTX as of Q3 2022.

  • Prospera Financial Services reported no remaining Repare Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Prospera Financial Services sold 122 Repare Therapeutics shares in Q3 2022, an estimated $2K.
  • Prospera Financial Services first reported a position in Repare Therapeutics in Q1 2022 and held it in 2 quarters.
  • Prospera Financial Services's Repare Therapeutics position peaked at $2K in Q2 2022.
  • 71 funds tracked by Wall St. Rank held Repare Therapeutics as of Q3 2022.

Based on Prospera Financial Services's 13F filing for Q3 2022, filed 27 Oct 2022.